The National Institute of Allergies and Infectious Diseases is leading COVID-19 clinical trial efforts through a large-scale network, called the COVID-19 Prevention Network (CoVPN). Dr. Jim Kublin, the executive director of operations program for CoVPN, shares more about this government-funded clinical trials network for COVID-19, the importance of diversity in research, and how tech is rapidly advancing medical discoveries.
HealthCast
Season 2
Episode 1
23m listen
Ensuring Participant Diversity in COVID-19 Vaccine Trials
Modern technology has the power to overcome clinical trial participation challenges.
-
Dr. Jim Kublin Executive Director of Operation Programs CoVPN
Related Content
-
Inside VA’s Lighthouse for App Development
Andrew Fichter discusses how Lighthouse is serving veterans and why it is necessary for modernization of veterans services.
24m listen -
Exploring the Link Between Climate Change and Public Health
Dr. John Balbus, Climate Change and Health Equity Director, HHS
35m listen -
Transparency Around Cyber Attacks Can Prevent Future Ones
Cybersecurity leader Suzanne Spaulding said implementing radical transparency in cybersecurity can benefit federal agencies and national security overall.
21m listen -
Emerging Tech Parallels Emerging Risks for VA Health Care
Amber Pearson, Executive Director, Information Security Policy and Strategy, VA
20m listen